Van ECK Associates Corp acquired a new stake in Genpact Limited (NYSE:G – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 175,680 shares of the business services provider’s stock, valued at approximately $7,545,000. Van ECK Associates Corp owned about 0.10% of Genpact at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. SRH Advisors LLC bought a new position in Genpact in the fourth quarter worth about $26,000. Summit Trail Advisors LLC increased its stake in shares of Genpact by 50.7% during the fourth quarter. Summit Trail Advisors LLC now owns 30,832 shares of the business services provider’s stock valued at $1,324,000 after acquiring an additional 10,375 shares during the period. Stephens Inc. AR increased its stake in shares of Genpact by 372.7% during the fourth quarter. Stephens Inc. AR now owns 61,643 shares of the business services provider’s stock valued at $2,648,000 after acquiring an additional 48,602 shares during the period. Empowered Funds LLC increased its stake in shares of Genpact by 1,942.3% during the fourth quarter. Empowered Funds LLC now owns 325,379 shares of the business services provider’s stock valued at $13,975,000 after acquiring an additional 309,447 shares during the period. Finally, Moloney Securities Asset Management LLC boosted its holdings in Genpact by 4.5% during the fourth quarter. Moloney Securities Asset Management LLC now owns 26,850 shares of the business services provider’s stock worth $1,153,000 after buying an additional 1,154 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
Genpact Price Performance
NYSE:G opened at $55.06 on Tuesday. The firm has a market cap of $9.71 billion, a PE ratio of 19.39, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $46.23 and its two-hundred day moving average price is $42.28.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 1.24%. The ex-dividend date of this dividend is Tuesday, March 11th. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio is presently 21.48%.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on G shares. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a research note on Friday, November 8th. Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho raised their price target on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Needham & Company LLC raised their price target on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a report on Friday, February 7th. Finally, TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and lifted their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Genpact presently has an average rating of “Hold” and an average price target of $48.44.
Check Out Our Latest Report on Genpact
Insider Buying and Selling at Genpact
In related news, CEO Balkrishan Kalra sold 9,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now owns 267,404 shares in the company, valued at approximately $12,407,545.60. This represents a 3.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,600 shares of company stock valued at $1,538,120. Corporate insiders own 2.80% of the company’s stock.
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- Why Are These Companies Considered Blue Chips?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- What is the S&P/TSX Index?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- What is Forex and How Does it Work?
- Conflicting Signals: Tempus AI’s Stock Market Rally
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.